Table 1.
Demographic and clinical data, quantitative radiological indexes, and qualitative CT severity scores for early and late treatment groups
Early treatment (n = 18) | Late treatment (n = 14) | p value | ||
---|---|---|---|---|
Age (years) | (Mean ± standard deviation) | 51 ± 19 | 52 ± 12 | 0.43 |
Gender | Male: female | 10:8 | 9:5 | 0.32 |
Height (cm) | (Mean ± standard deviation) | 163.4 ± 10.5 | 165.1 ± 9.2 | 0.59 |
Body weight (Kg) | (Mean ± standard deviation) | 62.2 ± 16.1 | 67.7 ± 10.3 | 0.17 |
Clinical symptoms | Number (%) | 18 (100) | 12 (85.7) | 0.07 |
Fever | Number (%) | 10 (55.6) | 8 (57.1) | 0.93 |
Time between onset of clinical symptoms and CT examination (days) | (Mean ± standard deviation) | 5.8 ± 3.3 | 5.9 ± 3.7 | 0.88 |
Quantitative indexes (%: mean ± standard deviation) |
Normal lung | 86.6 ± 5.6 | 86.9 ± 7.9 | 0.56 |
GGO | 7.1 ± 4.7 | 7.1 ± 4.8 | 0.99 | |
Reticulation or crazy paving | 3.7 ± 3.8 | 4.2 ± 4.7 | 0.81 | |
Emphysema | 0.7 ± 1.7 | 0.5 ± 1.1 | 0.59 | |
Nodular lesion | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.27 | |
Consolidation | 1.8 ± 2.3 | 1.2 ± 1.8 | 0.47 | |
Honeycombing | 0.1 ± 0.1 | 0.1 ± 0.1 | 0.66 | |
CT disease severity score | (Mean ± standard deviation) | 5.6 ± 4.7 | 7.1 ± 3.9 | 0.24 |
GGO ground-glass opacity